Introduction {#S0001}
============

Automated refraction has been conceptualized by researchers of visual science since prior to World War II. Collins[@CIT0001] first described the Electronic Refractionometer in 1937, a system that employed infrared light to execute an objective assessment of refractive error, "the accuracy of which is neither dependent on the mental reactions of the patient or the perception of the operator."[@CIT0002] The first functional, commercially available autorefractor did not appear until the 1970s, however. This device was developed by Safir, and marketed by Bausch & Lomb as the Ophthalmetron.[@CIT0003],[@CIT0004] Other early systems included the Dioptron (Coherent Radiation) and the 6600 Autorefractor (Acuity Systems, Inc.). As Collins had envisioned, all three of these devices utilized infrared light, although each relied on a different principle of examination to conduct an objective refraction in a manner previously acquired only by manual retinoscopy.[@CIT0005]--[@CIT0007]

The first fully subjective refracting system was developed by Humphrey[@CIT0008] in 1976, and was marketed as the Humphrey Vision Analyzer (HVA).[@CIT0009] This system had the capability to perform not only a spherocylindrical distance refraction, but near point evaluation and binocular testing as well. To its detriment, however, the HVA required its own refracting lane long enough to accommodate the exam chair, desk console, operator's chair and an office desk size projection system along with a 30 cm diameter concave mirror situated 3 m from the patient.[@CIT0010] Additionally, the HVA had a steep learning curve, and required that the operator has a detailed working knowledge of refractive principles and spectacle correction.

Modern autorefractors use a variety of strategies (eg, infrared videorefraction, LED-driven imaging using the Scheiner principle, wavefront aberrometry) to obtain objective assessments of refractive error. Subjective capabilities have also been added to many of these units to allow for refinement of the objective measurements. Several of these instruments can measure visual acuity before and after refraction, and sphere, cylinder and axis can be adjusted in accordance with patient responses to various targets presented. The ultimate goal of these technological advances has always focused on providing faster, more accurate results while maintaining the smallest possible footprint within the eye care practitioner's office. Moreover, the operation of these devices has been simplified to the point that a technician with very little training can produce reliable and repeatable results.

The voice assisted subjective refractor, a/k/a VASR (Vmax Vision, Maitland, FL, USA) is a unique digital refracting platform that utilizes wavefront aberrometry and point-spread function (PSF) technology combined with computer-generated artificial intelligence to conduct a complete objective and subjective refraction ([Figure 1](#F0001){ref-type="fig"}). It has been described as a "voice-guided self-refraction instrument"; the VASR prompts the patient through the subjective exam, and the patient responds to these prompts by means of a handheld remote. A technician monitors the process and validates visual acuity measurements, allowing the testing to proceed. The machine's footprint is approximately 12ʺ×18ʺ, and a technician can be trained to confidently operate the device in a matter of just 2--3 hrs, according to the manufacturer. The utility of such an instrument lies in its ability to provide rapid, reliable and repeatable results without the direct, physical oversight of a physician. This clinical study compared the measurements obtained with the VASR by an inexperienced technician -- in our case, a 2nd-year optometry student -- to traditional phoropter refraction conducted by an experienced optometric clinician.Figure 1The voice assisted subjective refractor, a/k/a VASR unit.

Materials and methods {#S0002}
=====================

This study followed the tenets of the Helsinki Declaration and was approved by the Institutional Review Board at Southern College of Optometry (Memphis, TN, USA). Subjects were recruited from a large optometric facility and included professional students as well as college employees. Inclusion criteria were as follows: ≥18 years of age, current spectacle or soft contact lens wearer, and best-corrected monocular distance visual acuity of 20/25 or better in each eye. There was no restriction on the magnitude of refractive error. Exclusion criteria consisted of: use of rigid gas-permeable contact lenses, history of refractive surgery, and a known diagnosis of ocular disease that would affect refractive measurements (eg, corneal degenerations, disease or defects; retinal abnormalities; media or lens opacities). All participants provided written informed consent before commencing the study. A total of 50 healthy subjects aged 22--55 (mean 28 years) were examined by a masked investigator (AK, CL, CN) using the TonoRef™ II autorefractor (Nidek; Fremont, CA, USA) to obtain the objective measurement, followed by subjective refinement through the phoropter (monocular subjective refraction with binocular balance). Subjects were then evaluated by a different investigator (JW) using the VASR to obtain an objective and subjective refraction result. Phoropter values were measured in 0.25 diopter steps for both sphere and cylinder components, while VASR data were calculated to the nearest 0.01 diopter for sphere and cylinder. Final corrected visual acuity was recorded for each eye after each procedure using standard Snellen targets. The total time was measured via stopwatch for both the traditional refraction and the VASR refraction. This process of evaluation by autorefractor, subjective phoropter refraction and VASR refraction was repeated twice: once later on the same day as the initial evaluation, and again on a subsequent visit to validate the repeatability of the measurements.

Results {#S0003}
=======

Fifty individuals participated in the study, however, one subject was excluded from analysis due to inadequate responsiveness during subjective testing. Sphere, cylinder and axis values from the right and left eyes were recorded for each procedure (ie, autorefraction, manifest refraction and VASR refraction), and equivalent sphere power was then calculated. Elapsed time for each individual procedure was also recorded, as well as the final-corrected visual acuity. To eliminate confusion, unilateral measurements (OD only) were analyzed with regard to refractive values.

Equivalent sphere power for the manifest refraction ranged from +1.13 to −12.75 (95% CI = −1.63 to −3.63), with a median of −2.50. For VASR, values ranged from +1.08 to −14.39 (95% CI = −1.26 to −3.46), with a median of −2.69. In this regard, a high correlation (R=0.99) was noted between the manifest and VASR ([Figure 2](#F0002){ref-type="fig"}). The datasets for both refractive methods displayed a negative skew (manifest = −1.23, VASR = −1.46), which is to be anticipated in this particular population; most of the subjects were graduate students, who tend to have a higher prevalence of myopia ([Figure 3](#F0003){ref-type="fig"}).[@CIT0011],[@CIT0012] Platykurtosis was also observed (manifest = 1.79, VASR = 2.85). Because of these factors, non-parametric analyses were performed using the Wilcoxon test.Figure 2Box plot of results (Manifest vs VASR).Figure 3Difference plot.

No statistically significant difference from the mean was noted for equivalent sphere values between manifest and VASR refractions (*P*=0.14). A high correlation was likewise noted for cylinder power (R=0.86, *P*=0.64) and axis (R=0.74, *P*=0.70). Corrected visual acuity measurements were similar for both groups; 16% of subjects had better acuity with VASR (≥1 line Snellen), while just 4% of subjects had worse acuity with VASR (≥1 line Snellen). 80% of subjects experienced a difference of \<1 line of Snellen between techniques.

In terms of elapsed time, manifest refraction averaged 5 mins, 38 s (range = 3:00--9:00), including autorefraction and subjective refinement with cross-cylinder testing and binocular balance. The VASR averaged 6 mins, 47 s (range = 4:35--11:03) to complete both eyes, including objective wavefront analysis and subjective PSF refinement. Measurement of final-corrected visual acuity was included in the time calculations.

To determine the repeatability of the procedures, a total of three refractive assessments were obtained for each subject. The first trial (T1) was conducted at a morning visit. The second (T2) was performed in the afternoon on same day but at least 6 hrs after T1, while the third (T3) was conducted on a separate day, at least 24 hrs but no more than 1 week after T2. Datasets for these trials were then assessed by ANOVA. The average differences noted upon repeat testing of spherical power were 0.02 D for the autorefractor (*P*=0.62), 0.02 D for the manifest refraction (*P*=0.55) and 0.07 D for VASR (*P*=0.58). The average differences noted upon repeat testing of cylinder power were 0.01 D for the autorefractor (*P*=0.49), 0.02 D for manifest refraction (*P*=0.11) and 0.03 D for VASR (*P*=0.39) ([Figures 4](#F0004){ref-type="fig"} and [5](#F0005){ref-type="fig"}). The average differences noted upon repeat testing of spherical equivalent power were 0.03 D for the autorefractor (*P*=0.43), 0.01 D for manifest refraction (*P*=0.98) and 0.10 D for VASR (*P*=0.23).Figure 4Repeatability of sphere and cylinder power.Figure 5Distribution of axis orientation.

Discussion {#S0004}
==========

Overall, the outcomes obtained with the VASR proved to be reliable and efficient with regard to accuracy, speed and repeatability. In the determination of spherocylindrical refractive error, the VASR results were not statistically different from those achieved using traditional phoropter methods by an experienced optometrist. Final, corrected visual acuity was similar between groups, and the differences noted between methods were not clinically significant.

The elapsed time for the VASR sequence was found to be slightly greater than for the traditional phoropter refraction, averaging 71 s longer. To this point, however, several considerations must be made. First, refraction time can vary greatly from patient to patient, and there is no normative value for this sequence of testing. In most cases with a cooperative individual, an experienced clinician can perform a complete objective and subjective refraction in roughly 5--10 mins. By means of comparison to other instruments, an evaluation of the Topcon (Tokyo, Japan) BV-1000 Automated Subjective Refraction System with a similar cohort revealed a mean test time of 9:45±0.11 mins.[@CIT0013] In our study, the VASR beat this time by nearly 3 mins. Second, it must be noted that the VASR -- like most autorefractors -- is designed to be operated by a technician rather than the optometrist or ophthalmologist. If this duty is delegated to office staff, then the small difference in time becomes negligible in comparison to the overall reduction in face-to-face time between doctor and patient.

Finally, the VASR was found to be highly repeatable with regard to the measurement of sphere power, cylinder power and spherocylindrical power. For all refractive methods -- autorefractor, manifest refraction and VASR -- the differences between measurements amounted to ≤0.10 diopters, which is neither clinically nor statistically significant.

The results of this study as displayed clearly demonstrate the accuracy, speed and repeatability of the VASR when compared to traditional refractive methods. The strengths of the study include a robust cohort of subjects, consistency of the operator performing VASR to eliminate testing bias, and testing on different days and at different times in order to account for fatigue. Variability was well-controlled by utilizing the same examination rooms and equipment for all subjects, with standardized lighting and acuity charts. However, this study is not without its limitations. The selected cohort consisted primarily of young, healthy individuals, a good majority of whom were familiar with the refractive process by virtue of being optometry students. This could possibly have biased the phoropter refraction results, causing them to be faster than might be anticipated in a similar age-matched population.

Additionally, the exclusion of subjects with ocular disease allowed for a less complicated and likely faster refractive assessment, both for the traditional manifest as well as the VASR. By that same process, however, we are unable to comment on the accuracy or repeatability of VASR in patients whose vision might be compromised due to such disorders like cataract or macular degeneration. A forerunner of VASR, the PSF Refractor (Vmax Vision) has previously been assessed by Trattler in keratoconus patients.[@CIT0014] That study of 14 patients (28 eyes) concluded that the PSF autorefractor "produces a more reliable and accurate refraction outcome in visually challenged patients such as keratoconus and cataracts. It is easier for the patient and provides the best corrected visual acuity when compared to a phoropter.[@CIT0014]"

It also bears mentioning that while the traditional manifest refraction in our study included binocular balancing, the VASR does not permit or facilitate any such binocularity. Some view this as a drawback of the VASR; others however have implied that such testing is unnecessary when utilizing a PSF system for refraction. The goal of the binocular balance is to equalize the accommodative response for the two eyes. The procedure is deemed necessary (in those with normal accommodative capacity and equivalent visual acuity in both eyes) because occlusion of the untested eye during monocular refraction can itself stimulate accommodation, and by Hering's law of equal innervation, this results in accommodation by the unoccluded eye as well.[@CIT0015] Hence, the binocular balance can be used as a means of determining the appropriate sphere power for each eye while preventing the clinician from "over-minusing" the patient during traditional phoropter refraction. The PSF target is different from standard Snellen optotypes, however, in that it is far more sensitive to defocus. Subjects tested with this system can perceive small changes from the optimal refraction much more clearly. The "smaller and darker" effect that can result with over-minusing behind the phoropter is perceived as blur by the same subject when viewing a PSF target. Geffen and Brujic[@CIT0016] in a study of 30 patients, assessed the results of subjective phoropter refraction with binocular balancing as compared to monocular refraction without binocular balance using the PSF Refractor. Their study concluded that, in 70% of patients, the spherical equivalent obtained with the PSF device was within 0.13 D of the phoropter refraction, and more than 0.25 D different in just 3%. PSF refraction results were equal to or better than those obtained with the phoropter binocular method in 93.5% of patients.[@CIT0016] This suggests that the inability to perform binocular testing with VASR may not be a detriment at all.

Another potential limitation of the study design involved the use of only the right eye data in the analysis. While this was considered a necessary element in order to maintain consistency of the data, the authors unknowingly introduced a potential bias by following this protocol. Since the right eye was consistently tested before the left, there may have been some "learning" by the subjects with regard to the Vmax. This could have potentially extended the testing time for the right eye as compared to the left eye. Randomization of testing with regard to the right and left eye might have yielded additional or different findings.

Finally, it was the authors' decision to use Snellen visual acuity measurement for this study in an effort to make the results as clinically relevant to the practicing clinician as possible. However, it should be noted that the VASR can also be programmed to measure visual acuity using ETDRS (i.e. LogMAR) as well as Lea or Allen symbols. These alternative strategies may be helpful for future studies evaluating different populations, and may potentially provide greater accuracy.
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